Lecanemab for Alzheimer’s Disease: A New Hope to Slow Memory Loss

Learn more about lecanemab, a new, FDA-approved medication to slow Alzheimer’s disease. Dr. Michael Rosenbloom, a behavioral neurologist at UW Medicine's Memory & Brain Wellness Center in Seattle explains how the drug works.
#AlzheimerDisease #AlzheimersAwareness